 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from scanned originals with text recognition applied 
(searchable text may contain so me errors and/or omissions) 
 
 
r); 
~v 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 Date: ~/JO/;J.01~ t'j,nor,-h/ 
1 =4 
JUDICIARY L.D. 1406 
(Filing No. st/Q._ ) 
Reproduced and distributed under the direction of the Secretary of the Senate. 
STATE OF MAINE 
SENATE 
128TH LEGISLATURE 
SECOND REGULAR SESSION 
COMMITTEE AMENDMENT " 6,, to S.P. 484, L.D. 1406, Bill, "An Act To 
Promote Prescription Drug Price Transparency" 
Amend the bill by striking out everything after the enacting clause and before the 
summary and inserting the following: 
'Sec. 1. 22 MRSA §8712, sub-§5 is enacted to read: 
5. Prescription drug information. By December 1, 2018 and annually thereafter, 
the organization shall provide a report containing the following information about 
prescription drugs, both brand name and generic: 
A. The 25 most frequently prescribed drugs in the State; 
B. The 25 costliest drugs as determined by the total amount spent on those drugs in 
the State; and 
C. The 25 drugs with the highest year-over-year cost increases as determined by the 
total amount spent on those drugs in the State. 
Sec. 2. Further data collection by Maine Health Data Organization. The 
Maine Health Data Organization shall develop a plan to collect data from manufacturers 
related to the cost and pricing of prescription drugs in order to provide transparency in 
and accountability for prescription drug pricing. The organization shall consult with 
other state and national agencies and organizations to determine how to institute such 
data collection. The organization shall submit the plan, its :findings and any 
recommendations for suggested legislation to the First Regular Session of the 129th 
Legislature no later than April 1, 2019. The joint standing committee of the Legislature 
having jurisdiction over judiciary matters may report out legislation related to 
prescription drug price transparency and the organization's :findings and recommendations 
to the First or Second Regular Session of the 129th Legislature. 
Sec. 3. Appropriations and allocations. The following appropriations and 
allocations are made. 
HEALTH DATA ORGANIZATION, MAINE 
Page 1 -128LR0994(03)-1 
COMMITTEE AMENDMENT 
~· ~~· 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 COMMITTEE AMENDMENT "(!;, " to S.P. 484, L.D. 1406 
Maine Health Data Organization 0848 
Initiative: Provides a one-time allocation to the Maine Health Data Organization to 
collect and present certain data to the Legislature and to develop a plan for further data 
collection. 
OTHER SPECIAL REVENUE FUNDS 
All Other 
OTHER SPECIAL REVENUE FUNDS TOTAL 
SUMMARY 2017-18 
$0 
$0 2018-19 
$25,000 
$25,000 
This amendment is the minority report of the Joint Standing Committee on Judiciary. 
It replaces the bill and directs the Maine Health Data Organization to analyze and post 
pharmacy data it currently collects to identify prescription drugs, both brand name and 
generic, that are the most frequently prescribed in the State, are the costliest drugs as 
determined by total spending in the State and have the highest year-over-year cost 
increases in the State. The Maine Health Data Organization is required to prepare the 
report annually, beginning with the first report by December 1, 2018. 
This amendment directs the Maine Health Data Organization to develop a plan to 
collect data from manufacturers that will help explain how prescription drug prices are 
established. The organization is required to work with other state and national agencies 
and organizations to determine how to conduct the data collection. The organization 
must submit the plan as well as any recommendations for legislation to the joint standing 
committee of the Legislature having jurisdiction over judiciary matters by April 1, 2019. 
That committee may report out legislation to the First or Second Regular Session of the 
129th Legislature. 
The amendment also adds an appropriations and allocations section. 
FISCAL NOTE REQUIRED 
(See attached) 
Page 2 -128LR0994(03)-1 
COMMITTEE AMENDMENT 
Approved: 03/22/18 ~ac. 
128th MAINE LEGISLATURE 
LD 1406 LR994(03) 
An Act To Promote Prescription Drug Price Transparency 
Fiscal Note for Bill as Amended by Committee Amendment "n" (S-L/S°J.) 
Committee: Judiciary 10 
Fiscal Note Required: Yes 
Fiscal Note 
FY 2017-18 FY 2018-19 Projections 
FY 2019-20 Projections 
FY 2020-21 
Appropriations/Allocations 
Other Special Revenue Funds 
Revenue $0 $25,000 $0 $0 
Other Special Revenue Funds $0 $25,000 $0 $0 
Fiscal Detail and Notes 
The bill includes a one-time allocation to the Maine Health Data Organization of $25,000 to collect and present 
certain data to the legislature and to develop a plan for further data collection. The Maine Health Data Organization 
has sufficient resources available to fund the allocation. 
LR0994(03) -Fiscal Note -Page 1 of 1 
